New Solutions to Help Improve Efficiency and Safety in Patient Care Areas and Create More Autonomous Process for In-house Sterile Compounding in Pharmacy
Technology, Intelligence, and Expert Services Showcased in Booth #2071 Designed to Address Rising Medication Management Costs
Omnicell, Inc. (NASDAQ: OMCL) announces results for its fiscal year and fourth quarter ended December 31, 2018.
Company Also Sweeps Category Leader Designations for Central Pharmacy Automation Hardware
Latest Automated Solutions Help Enhance Quality and Safety for Medication Management and In-house Sterile Compounding in Pharmacy and Patient Care Areas
New Technologies Target Zero Error, Fully Automated Medication Management
Automated Solutions Help Enhance Quality and Safety for Medication Management and In-house Sterile Compounding
Technology Evolution Affirms Omnicell’s Mission to Enable Pharmacists to Perform at the Top of their License
Omnicell, Inc. (NASDAQ: OMCL) announces results for its third quarter ended September 30, 2018.
Solutions Leverage Automation to Help Optimize Hospital Workflows, Improve Financial Performance and Enhance Patient Safety